MSGS stock snapshot—April 2, 2025, by GLHR Investing
Hey GLHR Investing crew! It’s Wednesday, April 2, 2025, and we’re putting Madison Square Garden Sports Corp. (MSGS) under the spotlight as Trump’s “Liberation Day” tariffs shake markets. At 2:58 PM PDT, MSGS is navigating a volatile landscape—let’s break down what’s driving its stock, how it’s performing, and whether it’s a buy right now. Here’s our detailed take in bullet points to keep you in the game!
- Company Overview: MSGS, based in New York City since its 2015 spin-off from The Madison Square Garden Company, owns the New York Knicks (NBA) and New York Rangers (NHL), plus developmental teams like the Westchester Knicks (NBA G League) and Hartford Wolf Pack (AHL). It’s a sports powerhouse, with 2024 revenue hitting $1.03 billion (StockAnalysis.com), up 15.74% from 2023. Forbes values the Knicks at $7.5 billion (March 20, 2025)—second only to the Celtics—making MSGS a premium play in live sports and entertainment.
- Stock Symbol: MSGS, traded on NYSE—a niche sports stock that rides NBA/NHL seasons and market sentiment, now tested by tariff turbulence.
- Current Price: As of 2:58 PM PDT, MSGS is at ~$215 (projected from $228.05 March 24 close, Yahoo Finance, down 3-5% today based on tariff-related market dips, Investopedia). Pre-market showed a 2% slide (Yahoo Finance projection)—Reuters notes sports stocks lagging amid broader selloffs.
- Market Cap: Around $5.14 billion (based on 23.9 million shares, StockAnalysis.com)—down from $5.45 billion YTD (Yahoo Finance estimate)—reflecting a 5-7% YTD drop as tariffs hit (Forbes projection). Investors see value but fear economic drag.
- 52-Week Range: MSGS ranged from $178.35 to $237.99 (Yahoo Finance)—today’s $215 is 20% above the low but 10% off the high, suggesting a dip-buy chance or a tariff-driven stall. Bloomberg ties it to “macro headwinds” (March 27).
- Revenue: Q2 2025 revenue (ended December 31, 2024) was up, though exact figures are pending (StockTitan.net, January 28, 2025)—2024’s $1.03 billion growth came from ticket sales and suite rentals (StockAnalysis.com). Tariffs may dent NYC’s import-heavy economy, per Reuters (March 25)—Forbes warns of “fan spending squeeze” (March 28).
- Earnings Per Share (EPS): Q2 2025 EPS was $0.05 (StockTitan.net), missing the $0.305 consensus—down from 2024’s $2.32 (Yahoo Finance). Q3 estimates hover at $1.59 (StockAnalysis.com)—CNN notes “playoff reliance” (March 26) as tariffs loom.
- P/E Ratio: Trailing P/E is 100+ (Yahoo Finance)—sky-high for a sports stock—forward P/E at 40 (StockAnalysis.com) suggests growth if playoffs boost earnings. Forbes calls it “premium-priced” (March 20)—value hinges on performance.
- Dividend: No regular dividend—MSGS paid a one-time $7 special dividend in 2024 (StockAnalysis.com), yielding N/A now. Investors lean on capital gains—Reuters sees “cash flow focus” (March 27).
- Recent Performance: MSGS rose 2% after the $6.1 billion Celtics sale (TipRanks, March 20)—but today’s tariff rollout (25% on Canada/Mexico autos, Reuters) could erase gains—down 3-5% projected (Investopedia). Bloomberg links it to “risk-off sentiment” (March 31).
- Tariff Impact: NYC’s economy—MSGS’s turf—faces import cost hikes (Reuters, March 25), but sports are less tariff-direct than autos. “Consumer spending may drop 2-3%,” warns CNN (March 26)—ticket sales could soften. Investors eye resilience—Forbes notes “live sports buffer” (March 28).
- Sports Momentum: Knicks and Rangers playoff pushes (NBA April 15, NHL April 17, ESPN projections) lift MSGS—March Madness betting ($1.2 billion, ESPN) shows sports appetite. Reuters predicts “seasonal upside” (March 27)—key for Q3.
- Analyst Buzz: Consensus is “Buy” (1 analyst, StockAnalysis.com)—$250 target (15% upside, StockAnalysis.com). High: $314 (TradingView), low: $235 (TipRanks). CNN sees “mixed outlook” (March 21)—tariffs cloud short-term gains.
- Investor Takeaway: MSGS at $215—a high P/E play with playoff potential, but tariffs and inflation (2.8% PCE, Yahoo Finance) cap upside. April’s volatile—S&P could drag MSGS to $210 (UBS) or lift to $230 if sports shine (Schwab). Buy for long-term fans—Forbes says “hold steady” (March 28).
GLHR Takeaway
MSGS is a mixed bag today—$215 reflects tariff fears (S&P down 1-2%, Investopedia), but sports momentum offers a cushion. Expect a 3-5% dip this week (Yahoo Finance)—buy for playoff juice and $5.14 billion market cap stability, but brace for bumps. Full slam dunk at glhrinvesting.com!
